NYSE : MD

Pediatrix Medical Group, Inc. — Financial statements

Healthcare · Medical Care Facilities · United States

Last price 29.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.27B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Pediatrix Medical Group, Inc. (MD) reported revenue of 1.96B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue1.96B1.91B2.01B1.99B1.97B1.91B
Cost of Revenue1.45B1.42B1.56B1.57B1.50B1.40B
Gross Profit511.69M493.70M454.34M421.56M467.03M513.24M
Selling, General & Admin249.94M240.79M238.44M227.54M231.40M263.36M
Operating Expenses273.71M262.62M270.66M263.71M267.03M295.50M
Operating Income237.98M231.09M183.68M157.85M200.00M217.74M
Interest Expense-33.30M-35.97M-40.74M-42.08M-39.70M-68.72M
Interest & Investment Income19.87M19.05M5.77M4.34M3.67M13.65M
Earnings From Equity Investments4.28M3.63M2.34M2.06M1.72M1.91M
EBT Excluding Unusual Items228.82M217.80M151.05M122.17M165.70M164.58M
Merger & Restructuring Charges-25.39M-22.27M-64.26M-2.22M-27.31M-22.10M
Impairment of Goodwill-150.64M-148.31M
Gain (Loss) on Sale of Investments-20.00M
Gain (Loss) on Sale of Assets20.91M-9.70M7.28M
Asset Writedown-27.79M
Other Unusual Items-57.02M-14.53M
Pretax Income203.43M216.43M-101.34M-48.36M81.37M135.23M
Income Tax Expense53.34M51.04M-2.27M12.05M18.81M27.24M
Earnings From Continuing Operations150.09M165.39M-99.07M-60.41M62.56M107.99M
Earnings From Discontinued Operations3.77M22.95M
Net Income to Company150.09M165.39M-99.07M-60.41M66.33M130.94M
Minority Interest in Earnings4.00K27.00K
Net Income150.09M165.39M-99.07M-60.41M66.33M130.96M
Net Income to Common150.09M165.39M-99.07M-60.41M66.33M130.96M
Shares Outstanding (Basic)79.88M84.08M83.33M82.20M83.47M84.83M
Shares Outstanding (Diluted)82.04M85.27M83.33M82.20M84.12M85.83M
EPS (Basic)1.881.97-1.19-0.730.791.54
EPS (Diluted)1.831.94-1.19-0.730.781.53
Free Cash Flow209.59M252.63M184.55M104.00M137.23M44.49M
Free Cash Flow Per Share2.562.962.211.261.630.52
Gross Margin26.12%25.80%22.57%21.14%23.68%26.86%
Operating Margin12.15%12.07%9.12%7.91%10.14%11.39%
Profit Margin7.66%8.64%-4.92%-3.03%3.36%6.85%
Free Cash Flow Margin10.70%13.20%9.17%5.21%6.96%2.33%
EBITDA261.75M252.91M215.91M194.02M235.64M249.88M
EBITDA Margin13.36%13.21%10.73%9.73%11.95%13.08%
D&A For EBITDA23.77M21.83M32.23M36.17M35.64M32.15M
EBIT237.98M231.09M183.68M157.85M200.00M217.74M
EBIT Margin12.15%12.07%9.12%7.91%10.14%11.39%
Effective Tax Rate26.22%23.58%23.11%20.14%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents311.92M375.24M229.94M73.26M9.82M387.39M
Short-Term Investments113.92M124.48M118.57M104.48M93.24M99.72M
Cash & Short-Term Investments425.84M499.72M348.51M177.74M103.06M487.11M
Accounts Receivable231.82M229.66M259.99M272.31M296.79M301.77M
Other Receivables8.47M12.64M12.61M7.57M14.25M
Receivables240.29M242.31M272.60M279.88M296.79M316.02M
Prepaid Expenses8.98M12.61M13.41M13.53M14.88M18.54M
Other Current Assets8.96M8.88M5.09M12.31M13.26M18.90M
Total Current Assets684.08M763.51M639.61M483.45M427.99M840.56M
Property, Plant & Equipment70.95M73.51M78.44M145.93M140.21M135.62M
Goodwill1.27B1.26B1.24B1.38B1.53B1.51B
Other Intangible Assets13.10M16.86M11.60M21.24M18.49M21.57M
Long-Term Deferred Tax Assets45.16M73.92M103.86M102.85M105.92M88.34M
Other Long-Term Assets57.89M58.16M76.60M82.17M123.18M131.03M
Total Assets2.14B2.25B2.15B2.22B2.35B2.72B
Accounts Payable25.89M37.22M46.43M34.59M31.86M36.65M
Accrued Expenses316.97M382.31M352.26M316.21M342.37M357.47M
Current Portion of Long-Term Debt179.95M25.00M18.75M12.50M12.50M
Current Portion of Leases11.02M13.40M14.50M23.49M23.99M22.17M
Current Income Taxes Payable1.90M984.00K2.17M2.16M16.27M11.07M
Total Current Liabilities535.73M458.91M434.11M388.95M426.98M427.37M
Long-Term Debt397.77M568.95M593.57M611.59M627.65M990.57M
Long-Term Leases23.26M27.27M35.49M54.07M52.94M53.08M
Long-Term Deferred Tax Liabilities61.43M57.02M34.25M34.31M33.64M41.41M
Other Long-Term Liabilities271.61M268.69M290.34M281.84M315.04M313.43M
Total Liabilities1.29B1.38B1.39B1.37B1.46B1.83B
Common Stock781.00K830.00K859.00K840.00K829.00K864.00K
Additional Paid-In Capital850.57M947.57M1.01B999.91M983.60M1.05B
Retained Earnings-83.15M-248.54M-149.47M-89.06M-155.39M
Comprehensive Income & Other-1.74M610.00K-1.07M-2.21M-3.73M1.32M
Total Common Equity849.62M865.85M764.94M849.06M891.63M896.49M
Minority Interest205.00K
Shareholders' Equity849.62M865.85M764.94M849.06M891.63M896.69M
Total Liabilities & Equity2.14B2.25B2.15B2.22B2.35B2.72B
Total Debt612.00M634.62M662.31M701.65M717.08M1.07B
Net Cash (Debt)-186.16M-134.89M-313.81M-523.90M-614.02M-578.72M
Net Cash Per Share-2.27-1.58-3.77-6.37-7.30-6.74
Filing Date Shares Outstanding76.19M81.07M84.13M82.77M81.84M85.33M
Total Common Shares Outstanding76.16M81.04M84.17M82.66M81.75M85.28M
Working Capital148.34M304.60M205.50M94.51M1.01M413.20M
Book Value Per Share11.1610.689.0910.2710.9110.51
Tangible Book Value-431.73M-411.74M-489.26M-556.35M-658.95M-630.51M
Tangible Book Value Per Share-5.67-5.08-5.81-6.73-8.06-7.39
Land2.03M2.03M2.03M2.03M2.03M
Buildings8.29M8.29M8.29M8.29M8.29M
Machinery161.20M155.36M208.04M235.19M224.52M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income150.09M165.39M-99.07M-60.41M66.33M130.96M
Depreciation & Amortization23.77M21.83M32.23M36.17M35.64M32.15M
Loss (Gain) From Sale of Assets-20.91M9.70M-7.28M
Asset Writedown & Restructuring Costs178.44M148.31M
Loss (Gain) From Sale of Investments20.00M
Stock-Based Compensation21.28M18.05M11.87M12.32M16.13M18.97M
Other Operating Activities54.37M48.56M-4.15M1.31M32.39M-37.67M
Change in Accounts Receivable-696.00K30.56M10.29M26.28M-5.54M-72.73M
Change in Accounts Payable-7.28M28.33M51.14M-11.92M420.00K21.33M
Change in Income Taxes-5.50M-1.21M-5.04M-21.68M18.23M-2.29M
Change in Other Net Operating Assets-6.89M-15.85M31.84M-4.31M18.73M30.32M
Operating Cash Flow226.88M271.09M206.57M137.32M166.94M76.74M
Capital Expenditures-17.29M-18.46M-22.02M-33.33M-29.71M-32.25M
Sale of Property, Plant & Equipment24.73M
Cash Acquisitions-11.00M-23.20M-8.17M-6.67M-28.17M-29.93M
Divestitures30.00M
Investment in Securities6.76M-3.18M-12.05M-8.99M-457.00K-18.56M
Other Investing Activities648.00K-3.46M6.83M807.00K1.38M2.93M
Investing Cash Flow-20.88M-18.30M-35.41M-48.18M-56.95M-53.07M
Long-Term Debt Issued235.50M470.00M1.48B
Long-Term Debt Repaid-20.75M-250.89M-489.12M-1.89B-762.66M
Net Debt Issued (Repaid)-25.20M-20.75M-15.39M-19.12M-405.17M-762.66M
Issuance of Common Stock2.94M3.18M3.64M4.91M5.40M6.85M
Repurchase of Common Stock-211.28M-86.68M-1.70M-919.00K-88.51M-4.72M
Other Financing Activities-604.00K-3.25M-1.03M-10.59M732.00K407.00K
Financing Cash Flow-234.14M-107.49M-14.48M-25.71M-487.55M-760.12M
Net Cash Flow-28.14M145.30M156.68M63.43M-377.57M-736.45M
Free Cash Flow209.59M252.63M184.55M104.00M137.23M44.49M
Free Cash Flow Margin10.70%13.20%9.17%5.21%6.96%2.33%
Free Cash Flow Per Share2.562.962.211.261.630.52
Levered Free Cash Flow141.31M190.33M173.92M69.20M136.08M61.19M
Unlevered Free Cash Flow162.13M212.81M199.39M95.50M160.89M104.14M
Cash Interest Paid34.38M34.38M40.00M42.28M116.23M86.54M
Cash Income Tax Paid1.72M1.72M4.70M30.80M26.91M54.73M
Change in Working Capital-20.37M41.83M88.24M-11.63M31.83M-23.37M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization2.34B1.80B1.11B770.31M1.22B2.32B
Enterprise Value2.53B1.98B1.57B1.35B1.93B2.93B
Last Close Price30.7121.3913.129.3014.8627.21
PE Ratio16.8110.8918.3517.71
Forward PE12.709.928.867.398.2916.25
PS Ratio1.190.940.550.390.621.21
PB Ratio2.752.081.450.911.362.59
P/FCF Ratio11.167.136.017.418.8752.14
P/OCF Ratio10.316.645.375.617.2930.23
PEG Ratio0.931.231.350.940.94
EV/Sales Ratio1.291.030.780.680.981.53
EV/EBITDA Ratio9.657.837.286.978.2011.72
EV/EBIT Ratio10.618.578.568.579.6613.45
EV/FCF Ratio12.057.848.5213.0114.0765.83
Debt / Equity Ratio0.720.730.870.830.801.19
Debt / EBITDA Ratio2.272.352.693.102.673.82
Debt / FCF Ratio2.922.513.596.755.2223.96
Net Debt / Equity Ratio0.220.160.410.620.690.65
Net Debt / EBITDA Ratio0.710.531.452.702.612.32
Net Debt / FCF Ratio0.890.531.705.044.4713.01
Asset Turnover0.900.870.920.870.780.63
Quick Ratio1.241.621.431.180.941.88
Current Ratio1.281.661.471.241.001.97
Return on Equity (ROE)17.25%20.28%-12.28%-6.94%7.00%13.13%
Return on Assets (ROA)6.86%6.57%5.25%4.32%4.93%4.48%
Return on Invested Capital (ROIC)16.47%16.98%14.98%10.97%10.32%12.42%
Return on Capital Employed (ROCE)14.80%12.90%10.70%8.60%10.40%9.50%
Earnings Yield5.95%9.19%-8.93%-7.84%5.45%5.65%
FCF Yield8.96%14.03%16.64%13.50%11.27%1.92%
Buyback Yield / Dilution3.57%-2.33%-1.37%2.28%1.99%-2.92%